📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dorothy Hodgkin/GlaxoSmithKline Studentship: MicroRNA and regulation of autoimmunity

Lead Research Organisation: Babraham Institute
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Regulation of gene expression is important in health and disease. For example our white blood cells fight infection by turning on a set of genes that produce inflammatory factors necessary to rid the infection. But a mismanagement of such resources in time or space can cause diseases such as septic shock and chronic inflammation, i.e. arthritis. Small RNA molecules dubbed micro-RNAs are emerging as powerful regulators of gene expression in many biological processes, including immunity, but also cancer, growth and development. Our project in collaboration with GlaxoSmithKline aims at defining the microRNAs that regulate the development and function of a special set of lymphocytes, the natural killer cells, which are key players in transplantation, reproduction, infection and cancer.

Planned Impact

unavailable

Publications

10 25 50